Stock News Pfizer says impact of Zantac litigation is unlikely to be material admin Admin posted on 2 years ago 276 views After a ~3% decline in its share price on Thursday amid concerns over the legal overhang related to recalled heartburn medication Zantac, Pfizer (PFE) sought to rule out a... Pfizer says impact of Zantac litigation is unlikely to be materialAug. 11, 2022 11:47 PM ETPfizer Inc. (PFE)HLN, GSKBy: Dulan Lokuwithana, SA News Editor2 Comments JHVEPhoto/iStock Editorial via Getty Images admin Follow Comments Comment 0 comment Best Oldest Newest Write the first comment for this!
Comments
0 comment